The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Edgewise Therapeutics Inc shares valued at $240,623 were sold by Russell Alan J on Feb 05 ’25. At $30.02 per share, Russell Alan J sold 8,015 shares. The insider’s holdings dropped to 14,863 shares worth approximately $0.39 million following the completion of this transaction.
Also, Russell Alan J sold 1,200 shares, netting a total of over 36,153 in proceeds. Following the sale of shares at $30.13 each, the insider now holds 14,863 shares.
Before that, KOCH KEVIN had sold 8,636 shares from its account. In a trade valued at $259,298, the President and CEO traded Edgewise Therapeutics Inc shares for $30.03 each. Upon closing the transaction, the insider’s holdings decreased to 8,636 shares, worth approximately $0.38 million.
As published in their initiating research note from Stifel on January 22, 2025, Edgewise Therapeutics Inc [EWTX] has been a Hold and the price target has been revised to $30. Analysts at Evercore ISI started covering the stock with ‘”an Outperform”‘ outlook in a report released in late November. As of March 07, 2024, Piper Sandler has initiated its “an Overweight” rating for EWTX. Earlier on May 01, 2023, Truist initiated its rating. Their recommendation was “a Buy” for EWTX stock.
Analyzing EWTX Stock Performance
During the last five days, there has been a drop of approximately -2.62%. Over the course of the year, Edgewise Therapeutics Inc shares have dropped approximately -1.16%. Shares of the company reached a 52-week high of $30.48 on 02/06/25 and a 52-week low of $23.08 on 01/13/25. A 50-day SMA is recorded $27.51, while a 200-day SMA reached $24.64. Nevertheless, trading volume fell to 0.9 million shares from 0.98 million shares the previous day.
Support And Resistance Levels for Edgewise Therapeutics Inc (EWTX)
According to the 24-hour chart, there is a support level at 25.61, which, if violated, would cause prices to drop to 24.84. In the upper region, resistance lies at 26.94. The next price resistance is at 27.50. RSI (Relative Strength Index) is 47.47 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.40, which suggests the price will decrease in the coming days. Percent R is at 48.50%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
